Bob Lederer RFL Communications, Inc.

You’re ready for some football, but how about those Super Bowl commercials? (RBDR–1/31/2014)

Sponsored this week by KL Communications (http://www.klcommunications.com)

This Sunday’s Super Bowl is almost as much about the commercials that will fill the time outs on the field as it is the 48th game in the series.

RBDR Producer Bob Lederer discussed the effectiveness of the advertising that will appear with experts in the field who can’t wait for the commercial breaks.

• Dialsmith CEO David Paull
• DG Head of Cross-Media Analytics George Musi
• Socratic Technologies Advertising Research Specialist Paul Shellenberg.

Super Bowl advertisers may not have the same goals in mind. How important is “buzz” versus reach, perceptions and effect on consumers? What different analyses will be done for the Super Bowl spots. How important is the most quoted Super Bowl advertising analyst, USA Today’s Ad Meter? We discussed these and other concerns.

—————————————————————————————————-

KL Communications is the expert in Customer Co-creation, with the proprietary CrowdWeaving platform that is powering the next generation of online insight communities.

========================================================

Research Business DAILY Report is produced by RFL Communications (rflonline.com), publisher of 4 market research newsletters that strongly complement these MR news videos:
• Research Business Report (technological and methodological changes that economically and constructively impact MR)
• Research Conference Report (summarizing conference speeches from around the world that present ideas, philosophies, methods, tactics, etc. that break new ground)
• Research Department Report (profiling the inner workings of MR departments at leading companies around the world)
• Pharma Market Research Report (the World’s Only Publication that exclusively covers the interests, challenges, opportunities, etc. of MR professionals inside pharmaceutical, health care, biotech and medical device companies)

Bob Lederer RFL Communications, Inc.

ThinkVine identifies correctable marketing mistake: devoting too much or too little too often to single marketing tool; CINT’s Bo Mattsson explains panel MR trends with large clients; IBM Interactive Experiences consultancy documents clients’ growing interest in CX (RBDR–1/30/14)

Today, sponsored by KL Communications (http://www.klcommunications.com):

1) ThinkVine provides more insight into correctable marketing mistakes.
2) IBM launches a new “Interactive Experience” consultancy that brings together design capabilities, user expertise expertise and research innovation and leadership.
3) CINT CEO Bo Mattsson discusses new trends in online panel research.

Look for our special RBDR Friday edition, January 31, featuring advertising experts who discuss the upcoming Super Bowl commercial extravaganza.

————————————————————————

KL Communications, THE expert in Customer Co-Creation, has proprietary a CrowdWeaving platform that is powering the next generation of online insight communities.

——————————————————————

To read KL Communications CEO Kevin Lonnie’s commentary on opportunities and implications of integrating customer co-creation into the MR realm, visit:

http://klcommunications.com/the-power-of-the-crowd-lies-in-co-creation-not-crowdsourcing/”

——————————————————————————-

Research Business DAILY Report is produced by RFL Communications (rflonline.com), publisher of 4 market research newsletters that strongly complement these MR news videos:
• Research Business Report (technological and methodological changes that economically and constructively impact MR)
• Research Conference Report (summarizing conference speeches from around the world that present ideas, philosophies, methods, tactics, etc. that break new ground)
• Research Department Report (profiling the inner workings of MR departments at leading companies around the world)
• Pharma Market Research Report (the World’s Only Publication that exclusively covers the interests, challenges, opportunities, etc. of MR professionals inside pharmaceutical, health care, biotech and medical device companies)